Eudaimonia Partners’s iPath Series B S&P 500 VIX Short-Term Futures ETN VXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$228K Buy
+513
New +$230K 0.04% 350
2021
Q1
Sell
-70
Closed -$76K 1665
2020
Q4
$76K Buy
70
+36
+106% +$46.8K 0.02% 509
2020
Q3
$54K Buy
34
+18
+113% +$32K 0.01% 547
2020
Q2
$35K Buy
+16
New +$38.5K 0.01% 581

Other funds holding VXX

Eudaimonia Partners's VXX Position: Q3 2021 in Review

Eudaimonia Partners opened a new position in iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) in Q3 2021: 513 shares worth $228K. The stake represents 0.04% of the portfolio and ranks #350 among its holdings. This is a return to the name: Eudaimonia Partners previously reported a position in VXX as recently as Q4 2020.

Eudaimonia Partners first reported a position in VXX in Q2 2020 and has held it in 4 quarters since. 119 funds tracked by Wall St. Rank hold VXX as of Q3 2021.

  • Eudaimonia Partners held 513 shares of iPath Series B S&P 500 VIX Short-Term Futures ETN worth $228K as of Q3 2021.
  • iPath Series B S&P 500 VIX Short-Term Futures ETN was a new Eudaimonia Partners position in Q3 2021.
  • iPath Series B S&P 500 VIX Short-Term Futures ETN made up 0.04% of Eudaimonia Partners's portfolio in Q3 2021, its #350 holding.
  • Eudaimonia Partners first reported a position in iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020 and has held it in 4 quarters since.
  • 119 funds tracked by Wall St. Rank held iPath Series B S&P 500 VIX Short-Term Futures ETN as of Q3 2021.

Based on Eudaimonia Partners's 13F filing for Q3 2021, filed 25 Oct 2021.